The guanylate-binding proteins: Emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase

Journal of Interferon and Cytokine Research

Volumn 31, Issue 1, 2011, Pages 89-97

  Vestal, Deborah J ^a   Jeyaratnam, Jonathan A ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYNAMIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE;

ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHLAMYDIA TRACHOMATIS; CRYSTAL STRUCTURE; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HYDROLYSIS; ISOPRENYLATION; LISTERIA MONOCYTOGENES; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; SALMONELLOSIS;

ANIMALS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; HUMANS; INTERFERONS; MULTIGENE FAMILY; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PRENYLATION;

EID: 78651514940     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0102     Document Type: Review

References (72)

1. Abdullah N, Srinivasan B, Modiano N, Cresswell P, Sau AK. 2009. Role of individual domains and indentification of internal gap in human guanylate binding protein-1. J Mol Biol 368:690-703.
2. Anderson SL, Carton JM, Lou J, Xing L, Rubin BY. 1999. Interferon- induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus. Virology 256:8-14.
3. Balasubramanian S, Nada S, Vestal DJ. 2006. The interferoninduced GTPase, mGBP-2, confers resistance to paclitaxelinduced cytotoxicity without inhibiting multinucleation. Cell Mol Biol 52:43-49.
4. Barbuddle SB, Chakraborty T. 2009. Listeria as an enteroinvasive gastointestinal pathogen. Curr Top Microbiol Immunol 337: 173-195.
5. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, Glowalla E, Leptin M, Howard JC. 2005. The interferoninducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 6:R92.
6. Bergsbaken T, Fink SL, Cookson BT. 2009. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99-109.
7. Boehm U, Guethlein L, Klamp T, Ozbek K, Schaub A, Futterer A, Pleffer, K, Howard JC. 1998. Two families of GTPases dominate the complex cellular response to IFN-g. J Immunol 161: 6715-6723.
8. Carter CC, Gorbacheva VY, Vestal DJ. 2005. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch Virol 150:1213-1220.
9. Cheng YE, Colonno RJ, Yin Fay H. 1983. Interferon induction of fibroblast proteins with guanylate binding activity. J Biol Chem 258:7746-7750.
10. Cheng YS, Patterson CE, Staeheli P. 1991. Interferon-induced guanylate-binding proteins lack an N(T)KXD consensus motif and bind GMP in addition to GDP and GTP. Mol Cell Biol 11:4717-4725.
11. Cheng Y-SE, Becker-Manley MF, Chow TP, Horan DC. 1985. Affinity purification of an interferon-induced human guanylate- binding protein and its characterization. J Biol Chem 260:15834-15839.
12. Costa da Silva R, Langoni H. 2009. Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res 105:893-898.
13. Decker T, Lew DJ, Cheng YS, Levy DE, Darnell JE Jr. 1989. Interactions of alpha- and gamma-interferon in the transcriptional regulation of the gene encoding a guanylate-binding protein. Embo J 8:2009-2014.
14. Decker T, Lew DJ, Darnell JE Jr. 1991. Two distinct alphainterferon- dependent signal transduction pathways may contribute to activation of transcription of the guanylatebinding protein gene. Mol Cell Biol 11:5147-5153.
15. Degrandi D, Konermann C, Beuter-Gunia C, Kresse A, Wurthner J, Kurig S, Beer S, Pfeffer K. 2007. Extensive characterization of IFN-induced GTPases mGBP1 to mGBP10 involved in host defense. J Immunol 179:7729-7740.
16. Duan Z, Foster R, Brakora KA, Yusuf, RZ, Seiden MV. 2005a. GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemother Pharmacol 57:25-33.
17. Duan Z, Lamendola DE, Duan Y, Yusaf R, Seiden MV. 2005b. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines. Cancer Chemother Pharmacol 55:277-285.
18. Fellenberg F, Hartmann TB, Dummer R, Usener D, Schadendorf D, Eichmuller S. 2004. GBP-5 splicing variants: new guanylate- binding proteins with tumor-associated expression and antigenicity. J Invest Dermatol 122:1510-1517.
19. Fink SL, Cookson BT. 2006. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell Microbiol 8:1812-1825.
20. Fink SL, Cookson BT. 2007. Pyroptosis and host cell death responses during Salmonella infection. Cell Microbiol 9:2562-2570.
21. Fres JM, Muller S, Praefcke GJK. 2010. Purification of the CaaX modified dynamin-related large GTPase hGBP-1 by coexpression with farnesyltransferase. J Lipid Res 51:2454-2459.
22. Gelb MH, Scholten JD, Sebolt-Leopold JS. 1998. Protein prenylation: from discovery to prospects for cancer treatment. Curr Opin Chem Biol 2:40-48.
23. Ghosh A, Praefcke GJK, Renault L, Wittinghofer A, Herrmann C. 2006. How guanylate-binding proteins acheive assembly stimulated processive cleavage of GTP to GMP. Nature 440: 101-104.
24. Gorbacheva VY, Lindner D, Sen GC, Vestal DJ. 2002. The IFNinduced GTPase, mGBP-2: role in IFN-g induced murine fibroblast proliferation. J Biol Chem 277:6080-6087.
25. Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, Sturzl M. 2001. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 20:5568-5577.
26. Guenzi E, Topolt K, Lubeseder-Martellato C, Jorg A, Naschberger E, Benelli R, Albini A, Sturzl M. 2003. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capabiliy of endothelial cells through inhibition of MMP-1 expression. EMBO J 22:3772-3782.
27. Haller O, Staeheli P, Gochs G. 2007a. Interferon-induced Mx proteins in antiviral host defense. Biochimie 6-7:812-818.
28. Haller O, Stertz S, Kochs G. 2007b. The Mx GTPase family of interferon-induced antiviral proteins. Microbes Infect 14-15: 1636-1643.
29. Howard J. 2008. The IRG proteins: a function in search of a mechanism. Immunobiology 213:367-375.
30. Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, Mandruzzato S, Ferrari N, Anfosso L, DellEva R, Noonan DM, and others. 2001. Idenfication of genes selectively regulated by IFNs in endothelial cells. J Immunol 178:1122-1135.
31. Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, and others. 2009. Antivral effects of the interferon- induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology 50:1727-1737.
32. Itsui Y, Sakamoto N, Kurasaki M, Kanazawa N, Tanabe Y, Koyama T, Takeda Y, Nakagawa M, Kakinuma S, Sekine Y, and others. 2006. Expressionl screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13:690-700.
33. Jutras I, Houde M, Currie, N, Boulais J, Duclos S, LaBoissiere S, Bonneil E, Kearney P, Thibault P, Paramithiotis E, and others. 2008. Modulation of the phagosome proteome by interferon-g. Mol Cell Proteomics 7:697-715.
34. Klamp T, Boehm U, Schenk D, Pfeffer K, Howard JC. 2003. A giant GTPase, very large inducible GTPase-1, is inducible by IFNs. J Immunol 171:1255-1265.
35. Kresse A, Konermann C, Degrandi D, Beuter-Gunia C, Wuerthner J, Pfeffer K, Beer, S. 2008. Analyses of murine GBP homology clusters based on in silico, in vitro and in vivo studies. BMC Genomics 9:158.
36. Laliberte J, Carruthers VB. 2008. Host cell manipulation by the human pathogen Toxoplasma gondii. Cell Mol Life Sci 65:1900-1915.
37. Leng J, Butcher BA, Denkers EY. 2009. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances. Parasite Immunol 31:717-728.
38. Lubeseder-Martellato C, Guenzi E, Jorg A, Topolt D, Naschberger E, Kremmer E, Zietz C, Tschachler E, Hutzer P, Schwemmle M, and others. 2002. Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol 161:1749-1759.
39. MacMicking JD. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol 25:601-609.
40. Maltese WA, Wilson AL, Erdman RA. 1996. Prenylationdependent interaction of Rab proteins with GDP dissociation inhibitors. Biochem Soc Trans 24:703-708.
41. Marshall CJ. 1993. Protein prenylation: a mediator of proteinprotein interactions. Science 259:1865-1866.
42. Messmer-Blust AF, Balasubramanian S, Gorbacheva VY, Jeyaratnam JA, Vestal DJ. 2010. The interferon-g-induced murine guanylate-binding protein-2 (mGBP-2) inhibits Rac activation during cell spreading on fibronectin and platelet-derived growth factor (PDGF) treatment: role for phosphatidylinositol 3-kinase (PI3-K). Mol Biol Cell 21:2514-2528.
43. Mirpuri J, Brazil JC, Berardinelli AJ, Nasr TR, Cooper K, Schnoor M, Lin PW, Parkos CA, Louis NA. 2010. Commensal Escherichia coli reduced epithelial apoptosis through IFN-aA mediated induction of guanylate binding protein-1 in human and murine models of developing intestine. J Immunol 184:7186-7195.
44. Modiano N, Lu YE, Cresswell P. 2005. Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-g-inducible cofactor. Proc Natl Acad Sci USA 102:8680-8685.
45. Moulder JW. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55:143-190.
46. Nantais DE, Schwemmle M, Stickney JT, Vestal DJ, Buss JE. 1996. Prenylation of an Interferon-g-induced GTP-binding protein: the human guanylate binding protein, huGBP-1. J Leukoc Biol 60:423-431.
47. Naschberger E, Croner RS, Merkel S, Dimmler A, Tripal P, Amann KU, Kremmer K, Brueckl WM, Papadopoulos T, Hohenadl C, and others. 2008. Angiostatic immune reaction in colorectal carcinomas: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer 123:2120-2129.
48. Naschberger E, Lugeseder-Martellato C, Meyer N, Gessner R, Kremmer E, Gessner A, Sturzl M. 2006. Human guanylatebinding protein-1 is a secreted GTPase present in increased concentrations in the cerebrospinal fluid of patients with bacterial meningitis. Am J Pathol 169:1088-1098.
49. Neun R, Richter MF, Staeheli P, Schwemmle M. 1996. GTPase properties of the interferon-induced human guanylatebinding protein 2. FEBS Lett 390:69-72.
50. Olszewski MA, Gray J, Vestal DJ. 2006. In silico genomic analysis of the human and murine guanylate binding protein (GBP) gene clusters. J Interferon Cytokine Res 26:328-352.
51. Pammer J, Reinisch C, Birner P, Pogoda K, Struzl M, Tschachler E. 2006. Interferon-a prevents apoptosis of endothelial cells after short-term exposure but induces replicative senescence after continuous stimulation. Lab Invest 86:997-1007.
52. Pfeffer SR, Dirac-Svejstrup AG, Soldati T. 1995. Rab GDP dissociation inhibitor: putting Rab GTPases in the right place. J Biol Chem 270:17057-17059.
53. Praefcke GJK, Geyer M, Schwemmle M, Kalbitzer HR, Herrmann C. 1999. Nucleotide-binding characteristics of human guanylate-binding protein 1 (hGBP-1) and identification of the third GTP-binding motif. J Mol Biol 292:321-332.
54. Praefcke GJK, Kloep S, Benscheid U, Lillie H, Prakash B, Herrmann C. 2004. Identification of residues in the human guanylate- binding protein 1 critical for nucleotide binding and cooperative GTP hydrolysis. J Mol Biol 344:257-269.
55. Prakash B, Praefcke GJK, Renault L, Wittinghofer A, Herrmann C. 2000a. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature 403:567-571.
56. Prakash B, Renault L, Praefcke GJK, Herrmann C, Wittinghofer A. 2000b. Triphosphate structure of guanylate-binding protein 1 and implications for nucleotide binding and GTPase mechanism. EMBO J 19:4555-4564.
57. Rando RR. 1996. Chemical biology of protein isoprenylation/ methylation. Biochim Biophys Acta 1300:5-16.
58. Roan NR, Starnbach MN. 2008. Immune-mediated control of Chlamydia infection. Cell Microbiol 10:9-19.
59. Rupper AC, Cardelli JA. 2008. Induction of guanylate binding protein 5 by gamma interferon increases susceptibility to Salmonella enterica serovar typhimurium-induced pyroptosis in RAW 264.7 cells. Infect Immun 76:2304-2315.
60. Schnoor M, Betanzos A, Weber DA, Parkos CA. 2009. Guanylate- binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-g and regulates barrier function through effects on apoptosis. Mucosal Immunol 2:33-42.
61. Schwemmle M, Staeheli P. 1994. The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP. J Biol Chem 269:11299-11305.
62. Shenoy AR, Kim B-H, Choi H-P, Matsuzawa T, Tiwari S, MacMicking JD. 2008. Emerging themes in IFN-g-induced macrophage immunity by p47 and p65 GTPase families. Immunobiology 212:771-784.
63. Sinensky M. 2000. Recent advances in the study of prenylated proteins. Biochim Biophys Acta 1484:93-106.
64. Stickney JT, Buss JE. 2000. Murine guanylate-binding protein: incomplete geranylgeranyl isoprenoid modification of an interferon- g-inducible guanosine triphosphate-binding protein. Mol Biol Cell 11:2191-2200.
65. Tietzel I, El-Haibi C, Carabeo RA. 2009. Human guanylate binding proteins potentiate the anti-chlamydia effects of inteferon- g. PLOS One 4:e6499.
66. Tripal P, Bauer M, Naschberger E, Mortinger T, Hohenadl C, Cornali E, Thurau M, Sturzl M. 2007. Unique features of different members of the human guanylate-binding protein family. J Interferon Cytokine Res 27:44-52.
67. Van den Broek MF, Muller U, Huang S, Zinkernagel RN, Aquet M. 1995. Immune defense in mice lacking type I and/or type II interferon receptors. Immunol Rev 148:5-18.
68. Vestal DJ. 2005. The guanylate binding proteins (GBPs): proinflammatory cytokine-induced members of the dynamin superfamily with unique GTPase activity. J Interferon Cytokine Res 25:435-443.
69. Vestal DJ, Buss JE, McKercher SR, Jenkins NA, Copeland NG, Kelner GS, Asundi VK, Maki RA. 1998. Murine GBP-2: a new IFN-g-induced member of the GBP family of GTPases isolated from macrophages. J Interferon Cytokine Res 18:977-985.
70. Vopel T, Syguda A, Britzen-Laurent N, Kunzelmann S, Ludemann MB, Dovengerds C, Sturzl M, Herrmann C. 2010. Mechanism of GTPase activity induced self-assembly of human guanylate binding protein 1. J Mol Biol 400:63-70.
71. Wehner M, Herrmann C. 2010. Biochemical properties of the human guanylate binding protein 5 and a tumor-specific truncated splice variant. FEBS J 277:1597-1605.
72. Weinlander K, Naschberger E, Lehmann MH, Tripal P, Paster W, Stockinger H, Hohenadl C, Sturzl M. 2008. Guanylate binding protein-1 inhibits spreading and migration of endothelial cells through induction of integrina4 expression. FASEBJ 22:4168-4178.